Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-01-17
2011-12-13
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200
Reexamination Certificate
active
08076081
ABSTRACT:
The present invention comprises, without limitation, systems, methods, and compositions for the detection, identification, and quantification, down to the single copy level, of human papillomavirus (HPV) in biological samples, including but not limited to, mammalian body fluids and cervix scrapings, for purposes of detection, treatment and/or management of cancer and dysplasia.
REFERENCES:
patent: 6368834 (2002-04-01), Senapathy et al.
patent: 2006/0160188 (2006-07-01), Kurnit et al.
patent: 94/26934 (1994-11-01), None
patent: 2004/030636 (2004-04-01), None
Ding et al. PNAS vol. 100:3059-3064. 2003.
Kan et al. British Journal of Cancer vol. 93:946-948. 2005.
Serth et al. Nucleic Acids Research vol. 26:4401-4408. 1998.
Knoth et al. Nucleic Acids Research vol. 16:10932. 1988.
Capone et al. Clinical Cancer Research vol. 6:4171-4175. 2000.
Brinkman et al. Journal of Clinical Microbiology vol. 40:3155-3161. 2002.
DeGaetani et al. Journal of Clinical Pathology vol. 52:103-106. 1999.
Perrons et al., “Detection and Genotyping of Human Papillomavirus DNA by SPF10 and MY09/11 Primers in Cervical Cells Taken from Women Attending a Colposcopy Clinic”Journal of Medical Virology2002, vol. 67, pp. 246-252, especially pp. 246-248.
Castle et al., “Comparisons of HPV DNA Detection by MY09/11 PCR Methods”Journal of Medical Virology2002, vol. 68, pp. 417-423, especially pp. 417-419.
Garland et al., “Prevalence of Sexually Transmitted Infections (Neisseria Gonorrhoeae, Chlamydia Trachomatis, Trichomonas Vaginalis and Human PapillomaVirus) in Female Attendees of a Sexually Transmitted Diseases Clinic in Ulaanbaatar, Mongolia,” 2001, vol. 9, pp. 143-146, especially pp. 143 and 145.
Fuessel Haws et al., “Nested PCR With the PGMY09/11 and GP5+/6+ Primer Sets Improves Detection of HPV DNA in Cervical Samples”,Journal of Virological Methods2004, vol. 122, pp. 87-93, especially pp. 87-90.
PCT International Search Report for PCT/IB06/00063; 4 pages.
Amexis, et al. Quantitative mutant analysis of viral quasispecies by chip-based matrix--assisted laser desorption/ionization time-of-flight mass spectrometry: PNAS, vol. 98, pp. 12097-12102 (2001).
Bosch, et al., Prevalence of Human Papilloma Virus in Cervical Cancer: A Worldwide Perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst, 1995. 87(11)- P. 796-802.
Castle, et al., Restricted Cross-Reactivity of Hybrid Capture 2 With Nononcogenic Human Papillomavirus Types, Cancer Epidemiol Biomarkers Prev, 2002.11(11): p. 1394-9.
Chang, et al. High-Risk Human Papillomaviruses May Have an Important Role in Non-Oral Habitsassociated Oral Squamous Cell Carcinomas in Taiwan. Am J Clin Pathol, 2003.120(6): p. 909-16.
Chin-Hong, et al. Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The Explore Study. J Natl Cancer Inst, 2005. 97(12): p. 896-905.
De Roda Husman, et al. The Use of General Primers GP5 and GP6 Elongated A T Their 3' Ends With Adjacent Highl Y Conserved Sequences Improves Human Papillomavirus Detection by PCR, J Gen Virol, 1995.76 (PT 4): p. 1057-62.
Ding, et al. Quantitative Analysis of Nucleic Acids—The Last Few Years of Progress. J Biochem Mol Biol, 2004. 37(1): p. 1-10.
Elvidge, et al., Developmentand Evaluation of Real Competitive PCR for High-Throughput Quantitative Applications. Anal Biochem, 2005.339(2): p. 231-41.
Gillison, et al., Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers. J Nail Cancer Inst, 2000. 92(9): p. 709-20.
Gravitt, et al. Genotyping of 27 Human Papilloma Virus Types by Using L 1 Consensus PCR Products BYA Single-Hybridization, Reverse Line Blot Detection Method. J Clin Microbiol, 1998.36(10): p. 3020-7.
Ha, et al., Real-Time Quantitative PCR Demonstrates Low Prevalence of Human Papillomavirus Type 16 in Premalignant and Malignant Lesions of the Oral Cavity. Clin Cancer Res, 2002. 8(5): p. 1203-9.
Heid, et al. Real Time Quantitative PCR, in Genome Research. 1996. p. 986-994.
Herrero, et al., Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst, 2003, 95(23): p. 1772-83.
Jacobs, et al., Group-Specific Differentiation Between Highand Low-Risk Human Papillomavirus Genotypes by General Primermediated PCR and Two Cocktails of Oligonucleotide Probes. J Clin Microbiol, 1995.33(4): p. 901-5.
Jurinke, et al. “Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera” Genetic Analysis: Biomolecular Engineering, vol. 14, pp. 97-102 (1998).
Khaled, et al. Human Papilloma Virus Infection and Overexpression of P53 Protein in Bilharzial Bladder Cancer Tumori, 2001. 87(4): p. 256-61.
Koch, et al., Head and Neck Cancer in Nonsmokers: A Distinct Clinical and Molecular Entity. Laryngoscope, 1999. 109(10): p. 1544-51.
McKaig, et al., Human Papillomavirus and Head and Neck Cancer: Epidemiologyand Molecular Biology. Head Neck, 1998. 20(3): p. 250-65.
Moberg, et al. Type-Specific Associations of Human Papillomavirus Load With Risk of Developing Cervical Carcinoma in Situ. Int J Cancer, 2004.112(5): p. 854-9.
Munoz, et al., Epidemiologic Classification of Human Papillomavirus Types Associated With Cervical Cancer. N Engi J Med, 2003.348(6): p. 518-27.
Nam, et al. Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins. Science, 2003. 301(5841): p. 1884-6.
Nam, et al., Bio-Bar-Code-Based DNA Detection With PCR-Like Sensitivity. Jam Chem Soc, 2004.126(19): p. 5932-3.
Nelson, et al. A Novel and Rapid PCR-Based Method for Genotyping Human Papillomaviruses in Clinical Samples. J Clin Microbiol, 2000. 38(2): p. 688-95.
Neville, et al. Oral Cancer and Precancerous Lesions. CA Cancer J Clin, 2002. 52(4): p. 195-215.
Obiso, et al. Digene Corporation. Pharmacogenomics, 2004. 5(1): p. 129-32.
Polak, et al., Hybrid Capture /I HPV Test Detects At Least 15 Human Papilloma Virus Genotypes Not Included in Its Current High Risk Probe Cocktail. J Clin Virol, 2002. 25 Suppl 3: p. S89-97.
Rock, et al., Prevention of Cervix Cancer. Crit Rev Oncol Hematol, 2000. 33(3): p. 169-85.
Scheffner, et al., The E6 Oncoprotein Encoded by Human Papillomavirus Types 16 and 18 Promotes the Degradation of P53. Cell, 1990. 63(6): p. 1129-36.
Schwartz, et al., Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study. Otolaryngol Head Neck Surg, 2001.125(1): p. 1-9.
Schwartz, et al., Oral Cancer Risk in Relation to Sexual History and Evidence of Human Papillomavirus Infection. J Natl Cancer Inst, 1998.90(21): p. 1626-36.
Seybolt, et al. [Exfoliative Cytology: Its Value in the Diagnosis of Cancer.]. Arch Med Cuba, 1953.4(6): p. 579-86.
Sjöholm, et al. “Multiplex Detection of Human Herpesviruses from Archival Specimens by Using Matrix-Assist Laser Desorption Ionization—Time of Flight Mass Spectrometry” J. Clin. Microbiol., vol. 46, pp. 540-5.
Stroun, et al., Isolation and Characterization of DNA From the Plasma of Cancer Patients. Eur J Cancer Clin Oncol, 1987.23(6): p. 707-12.
Tang, et al. Mining Disease Susceptibility Genes Through SNP Analyses and Expression Profiling Using Maldi-Tof Mass Spectrometry. J Proteome Res. 2004.3(2): p. 218-27.
Thompson, et al. Expression of Human Papillomavirus Type 6 E1, E2, L 1 and L2 Open Reading Frames inEscherichia coli. Gene, 1987.56(2-3): p. 289-95.
Tost, et al. “Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications” Clin. Biochem., vol. 38, pp, 335-50 (2005).
van den Boom, et al. “MALDI-TOF MAS: a platform technology for genetic discovery” Int. J, Mass Spectrometry, vol. 238, pp. 173-86 (2004).
Van Ham, et al., Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche Amplicor HPV Test As a Means to Screen for HPV Genotypes Associated With a Higher Risk of Cervical Disorders
Kane Michael D.
Kurnit David M.
Casimir Jones SC
Horlick Kenneth R.
The Regents of the University of Michigan
LandOfFree
Systems, methods, and compositions for detection of human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems, methods, and compositions for detection of human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems, methods, and compositions for detection of human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4309438